Sunday 30 September 2012

Aggressive Cancer Exploits MYC Oncogene To Amplify Global Gene Activity

For a cancer patient, over-expression of the MYC oncogene is a bad omen. Scientists have long known that in tumor cells, elevated levels of MYC's protein product, c-Myc, are associated with poor clinical outcomes, including increased rates of metastasis, recurrence, and mortality. Yet decades of research producing thousands of scientific papers on the subject have failed to consistently explain precisely how c-Myc exerts its effects across a broad range of cancer types. Until now, that is... via Health News from Medical News Today Read More Here..

No comments:

Post a Comment